SEC Form 4 · accession 0000899243-19-004314
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Braunstein
Director
Period of report
Feb 19, 2019
Accepted (ET)
Feb 20, 2019 · 6:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.81 | Feb 19, 2019 | A | 26,342 | A | — | Feb 18, 2029 | Common Stock | 26,342 | 26,342 | D |
Explanation of responses
- F1This option was granted on February 19, 2019 and is scheduled to vest in equal monthly installments through February 19, 2022, subject to continued service.